Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies

Related

• Diabetes·6 Oct 2026

  Protein loss promotes a non-dividing state in kidney cells

  

• Nature Medicine·4 Oct 2026

  Semaglutide may protect kidneys by reducing vascular resistance

  

• Nature Aging·2 Oct 2026

  Kidney tubular epithelial cells drive accelerated epigenetic aging in disease

• Clinical Journal of the American Society of Nephrology·4 Oct 2026

  SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes